Bethany L DiPrete1, Brian W Pence2, David J Grelotti3, Bradley N Gaynes4. 1. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America. Electronic address: diprete@email.unc.edu. 2. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America. 3. Department of Psychiatry, University of California, San Diego, CA, United States of America. 4. Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Abstract
BACKGROUND: Prescription records, manual chart review, and patient self-report are each imperfect measures of depression treatment in HIV-infected adults. METHODS: We compared antidepressant prescription records in an electronic data warehouse with antidepressant treatment and psychotherapy identified via manual chart review and self-report for patients at 6 academic HIV treatment centers. We examined concordance among these three sources, and used latent class analysis (LCA) to estimate sensitivity and specificity of each measure. RESULTS: In our charts sample (n = 586), 59% had chart indication of "any depression treatment" and 46% had a warehouse prescription record. Antidepressant use was concordant between charts and data warehouse for 77% of the sample. In our self-report sample (n = 677), 52% reported any depression treatment and 43% had a warehouse prescription record. Self-report of antidepressant treatment was consistent with prescription records for 71% of the sample. LCA estimates of sensitivity and specificity for "any depression treatment" were 67% and 90% (warehouse), 87% and 75% (self-report), and 96% and 77% (chart). LIMITATIONS: There is no gold standard to measure depression treatment. Antidepressants may be prescribed to patients for conditions other than depression. The results may not be generalizable to patient populations in non-academic HIV clinics. Regarding LCA, dependence of errors may have led to overestimation of sensitivity and specificity. CONCLUSIONS: Prescription records were largely concordant with self-report and chart review, but there were discrepancies. Studies of depression in HIV-infected patients would benefit from using multiple measures of depression treatment or correcting for exposure misclassification.
BACKGROUND: Prescription records, manual chart review, and patient self-report are each imperfect measures of depression treatment in HIV-infected adults. METHODS: We compared antidepressant prescription records in an electronic data warehouse with antidepressant treatment and psychotherapy identified via manual chart review and self-report for patients at 6 academic HIV treatment centers. We examined concordance among these three sources, and used latent class analysis (LCA) to estimate sensitivity and specificity of each measure. RESULTS: In our charts sample (n = 586), 59% had chart indication of "any depression treatment" and 46% had a warehouse prescription record. Antidepressant use was concordant between charts and data warehouse for 77% of the sample. In our self-report sample (n = 677), 52% reported any depression treatment and 43% had a warehouse prescription record. Self-report of antidepressant treatment was consistent with prescription records for 71% of the sample. LCA estimates of sensitivity and specificity for "any depression treatment" were 67% and 90% (warehouse), 87% and 75% (self-report), and 96% and 77% (chart). LIMITATIONS: There is no gold standard to measure depression treatment. Antidepressants may be prescribed to patients for conditions other than depression. The results may not be generalizable to patient populations in non-academic HIV clinics. Regarding LCA, dependence of errors may have led to overestimation of sensitivity and specificity. CONCLUSIONS: Prescription records were largely concordant with self-report and chart review, but there were discrepancies. Studies of depression in HIV-infectedpatients would benefit from using multiple measures of depression treatment or correcting for exposure misclassification.
Authors: Alexander C Tsai; Dan H Karasic; Gwendolyn P Hammer; Edwin D Charlebois; Kathy Ragland; Andrew R Moss; James L Sorensen; James W Dilley; David R Bangsberg Journal: Am J Public Health Date: 2012-06-21 Impact factor: 9.308
Authors: Brian W Pence; Bradley N Gaynes; Julie L Adams; Nathan M Thielman; Amy D Heine; Michael J Mugavero; Teena McGuinness; James L Raper; James H Willig; Kristen G Shirey; Michelle Ogle; Elizabeth L Turner; E Byrd Quinlivan Journal: AIDS Date: 2015-09-24 Impact factor: 4.177
Authors: Angela M Bengtson; Brian W Pence; Bradley N Gaynes; E Byrd Quinlivan; Amy D Heine; Julie K OʼDonnell; Heidi M Crane; W Christopher Mathews; Richard D Moore; Daniel Westreich; Conall OʼCleirigh; Katerina Christopoulos; Matthew J Mimiaga; Michael J Mugavero Journal: J Acquir Immune Defic Syndr Date: 2016-12-01 Impact factor: 3.731
Authors: Steven A Safren; C Andres Bedoya; Conall O'Cleirigh; Katie B Biello; Megan M Pinkston; Michael D Stein; Lara Traeger; Erna Kojic; Gregory K Robbins; Jonathan A Lerner; Debra S Herman; Matthew J Mimiaga; Kenneth H Mayer Journal: Lancet HIV Date: 2016-09-19 Impact factor: 12.767
Authors: Bethany L DiPrete; Brian W Pence; Angela M Bengtson; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Riddhi Modi; Bradley N Gaynes Journal: AIDS Behav Date: 2019-03